Hemodynamic effects of short-term infusion of recombinant human atrial natriuretic peptide (rhANP) for congestive heart failure: a randomized, double-blind, placebo-controlled study
机构：[1]Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp, Beijing, Peoples R China;[2]Peking Union Med Coll, Beijing, Peoples R China;[3]Beijing Anzhen Hosp, Beijing, Peoples R China首都医科大学附属安贞医院
第一作者机构：[1]Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp, Beijing, Peoples R China;[2]Peking Union Med Coll, Beijing, Peoples R China;
推荐引用方式(GB/T 7714)：
Wang Pengbo,Wang Guogan,Huang Jie,et al.Hemodynamic effects of short-term infusion of recombinant human atrial natriuretic peptide (rhANP) for congestive heart failure: a randomized, double-blind, placebo-controlled study[J].CARDIOLOGY.2014,129:116-117.
APA：
Wang, Pengbo,Wang, Guogan,Huang, Jie,Tan, Huiqiong,Liu, WenXian...&Bai, Shugong.(2014).Hemodynamic effects of short-term infusion of recombinant human atrial natriuretic peptide (rhANP) for congestive heart failure: a randomized, double-blind, placebo-controlled study.CARDIOLOGY,129,
MLA：
Wang, Pengbo,et al."Hemodynamic effects of short-term infusion of recombinant human atrial natriuretic peptide (rhANP) for congestive heart failure: a randomized, double-blind, placebo-controlled study".CARDIOLOGY 129.(2014):116-117
